Make drug prices transparent — pass Senate Bill 665
There’s a little-known reality in the prescription drug market: prices aren’t always what they seem. In many cases, a lower price is available — but pharmacies typically only share it if you ask. Without that question, consumers can unknowingly pay far more than necessary.
On April 15, the House Commerce and Consumer Affairs Committee has an opportunity to make a meaningful difference for New Hampshire families by passing Senate Bill 665 sponsored by Senator Denise Ricciardi, R-Bedford.
Most consumers assume their insurance guarantees the lowest prescription price. Too often, that isn’t the case. Unless you specifically ask about discounts or coupons, you may pay more than necessary — and pharmacies typically aren’t required to tell you.
I experienced this firsthand. I was quoted $95 for a prescription using insurance. After asking about available discounts, the price dropped to $35. Many people never think to ask — and end up overpaying as a result.
Senate Bill 665 would require pharmacies to inform customers when a lower price is available. That’s not complicated policy — it’s basic transparency.
At a time when families are struggling with rising costs, no one should have to guess whether they’re getting the best price on essential medication.
New Hampshire has the chance to lead on this issue with a simple, consumer-focused reform.
I urge Chairman Hunt and the committee to pass Senate Bill 665.